How COVID-19 has affected Medicrea — 6 full-year & quarterly insights

Spinal Tech

Medicrea reported its full-year 2019 and first-quarter 2020 financial results, posting a $17 million (15.6 million euro) loss on the year. 

What you should know:

1. Despite the overall loss, Medicrea grew its sales from $35.2 million (32.3 million euros) in 2018 to $35.7 million (32.7 million euros) in 2019. 

2. The company's EBITDA also grew from $654,540 (600,000 euros) in 2018 to $3.4 million (3.1 million euros) in 2019. 

3. Medicrea said sales were up 16 percent before the COVID-19 pandemic on a year-over-year basis. In the U.S., sales rose 10 percent year over year. 

4. The COVID-19 pandemic has affected Medicrea heavily. The company suffered a 5 percent drop in first-quarter year-over-year sales. 

5. To mitigate losses from the pandemic, the company capitalized on a European tax credit, collected 40 percent of the trade receivables on its balance sheet, placed its U.S.-based employees on furlough, and sought financial relief from its main creditor. 

6. Medicrea also applied for a $1 million loan through the Paycheck Protection Program. 

Note: All monetary conversions were current as of April 13. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like